The mechanism is that DC-SIGN activation promotes the transcription of MMP-9 and VEGF via PI3K/Akt/β-catenin pathway and suppresses the transcription of miR-185 via β-catenin/TCF1/LEF1 pathway, which eventually promotes metastasis of CRC (165). The gene discussed is CD209; the disease is colorectal carcinoma.